Date published: 2026-3-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vatalanib Dihydrochloride (CAS 212141-51-0)

5.0(1)
Write a reviewAsk a question

Alternate Names:
N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine dihydrochloride
Application:
Vatalanib Dihydrochloride is a potent inhibitor of EGFR- and RET-dependent tumor cell proliferation and survival
CAS Number:
212141-51-0
Purity:
≥96%
Molecular Weight:
419.73
Molecular Formula:
C20H15ClN42HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Vandetanib inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. Vandetanib is the active ingredient in the drug sold under the trade name Zactima® and is approved for treatment of patients with follicular, medullary, anaplastic, and locally advanced and metastatic papillary thyroid cancer.


Vatalanib Dihydrochloride (CAS 212141-51-0) References

  1. Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis.  |  Herbst, RS., et al. 2007. Expert Opin Investig Drugs. 16: 239-49. PMID: 17243944

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Vatalanib Dihydrochloride, 5 mg

sc-202379
5 mg
$125.00

Vatalanib Dihydrochloride, 25 mg

sc-202379A
25 mg
$374.00